Online citations, reference lists, and bibliographies.
← Back to Search

Genetic Variants Associated With Increased Risk Of Malignant Pleural Mesothelioma: A Genome-Wide Association Study

G. Matullo, S. Guarrera, M. Betti, G. Fiorito, D. Ferrante, Floriana Voglino, G. Cadby, C. Di Gaetano, F. Rosa, A. Russo, A. Hirvonen, E. Casalone, S. Tunesi, M. Padoan, M. Giordano, A. Aspesi, C. Casadio, F. Ardissone, E. Ruffini, P. Betta, R. Libener, R. Guaschino, E. Piccolini, M. Neri, A. Musk, N. de Klerk, J. Hui, J. Beilby, A. James, J. Creaney, B. Robinson, S. Mukherjee, L. Palmer, D. Mirabelli, D. Ugolini, S. Bonassi, C. Magnani, I. Dianzani
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Asbestos exposure is the main risk factor for malignant pleural mesothelioma (MPM), a rare aggressive tumor. Nevertheless, only 5–17% of those exposed to asbestos develop MPM, suggesting the involvement of other environmental and genetic risk factors. To identify the genetic risk factors that may contribute to the development of MPM, we conducted a genome-wide association study (GWAS; 370,000 genotyped SNPs, 5 million imputed SNPs) in Italy, among 407 MPM cases and 389 controls with a complete history of asbestos exposure. A replication study was also undertaken and included 428 MPM cases and 1269 controls from Australia. Although no single marker reached the genome-wide significance threshold, several associations were supported by haplotype-, chromosomal region-, gene- and gene-ontology process-based analyses. Most of these SNPs were located in regions reported to harbor aberrant alterations in mesothelioma (SLC7A14, THRB, CEBP350, ADAMTS2, ETV1, PVT1 and MMP14 genes), causing at most a 2–3-fold increase in MPM risk. The Australian replication study showed significant associations in five of these chromosomal regions (3q26.2, 4q32.1, 7p22.2, 14q11.2, 15q14). Multivariate analysis suggested an independent contribution of 10 genetic variants, with an Area Under the ROC Curve (AUC) of 0.76 when only exposure and covariates were included in the model, and of 0.86 when the genetic component was also included, with a substantial increase of asbestos exposure risk estimation (odds ratio, OR: 45.28, 95% confidence interval, CI: 21.52–95.28). These results showed that genetic risk factors may play an additional role in the development of MPM, and that these should be taken into account to better estimate individual MPM risk in individuals who have been exposed to asbestos.
This paper references
10.1016/J.CANCERGENCYTO.2007.05.007
Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
P. Lennon (2007)
Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.
C. Lu (2011)
A Language and Environment for Statistical Computing. R Foundation for Statistical Computing
R Development (2009)
10.1093/HMG/DDH164
Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.
C. Storlazzi (2004)
10.1177/107327480601300402
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
Pvt1encoded microRNAs in oncogenesis
GB Beck-Engeser (2008)
A review of Human carcinogens: Metals, arsenic, dusts, and fibres. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Twelfth Edition
(2011)
10.1016/j.mrrev.2008.02.002
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
M. Neri (2008)
10.1016/j.coi.2011.12.009
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.
Suzanne L. Topalian (2012)
Aberrant EVI 1 expression in acute myeloid leukemias associated with the t ( 3 ; 8 ) ( q 26 ; q 24 )
PA Lennon (2007)
10.1158/1078-0432.CCR-06-2492
Relaxin Promotes Prostate Cancer Progression
S. Feng (2007)
10.1016/J.MRFMMM.2006.02.005
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
I. Dianzani (2006)
10.1371/journal.pgen.1000529
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
Bryan Howie (2009)
XRCC 1 and ERCC 1 variants modify malignant mesothelioma risk : A case - control study
M Betti (2011)
10.1073/pnas.1115128108
PRDM1 is a tumor suppressor gene in natural killer cell malignancies
Can Küçük (2011)
10.1158/1055-9965.epi-08-0524
The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.
D. Ugolini (2008)
10.1016/j.cell.2012.03.003
MYC on the Path to Cancer
C. Dang (2012)
10.1158/1078-0432.CCR-06-2882
Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Yinghui Guan (2007)
10.1038/ng1847
Principal components analysis corrects for stratification in genome-wide association studies
A. Price (2006)
Algorithm AS 136: A K-Means Clustering Algorithm
JA Hartigan (1979)
10.1038/ng.912
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
10.1080/10937404.2011.556052
Factors that Impact Susceptibility to Fiber-Induced Health Effects
J. Below (2011)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1186/1471-2105-11-288
GWAMA: software for genome-wide association meta-analysis
R. Mägi (2009)
10.1158/1055-9965.EPI-08-0524
The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract Diseases
Ugolini Donatella (2008)
10.1016/j.mrfmmm.2011.01.001
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
M. Betti (2011)
Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis
L. Migliore (2014)
10.1128/MCB.24.17.7514-7523.2004
The Thyroid Hormone Receptor Is a Suppressor of ras-Mediated Transcription, Proliferation, and Transformation
S. García-Silva (2004)
10.1111/J.0006-341X.1999.00997.X
Genomic control for association studies.
B. Devlin (1999)
10.1016/J.MRREV.2007.08.001
Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor.
D. Ugolini (2008)
10.1158/0008-5472.CAN-06-2301
RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Ernesta Fagiani (2007)
10.1016/J.EJCA.2007.09.018
Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.
A. Marinaccio (2007)
10.1128/MCB.00396-10
The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression
Helen Yu (2010)
10.1080/10937404.2011.556047
Pulmonary Endpoints (Lung Carcinomas and Asbestosis) Following Inhalation Exposure to Asbestos
B. Mossman (2011)
10.1016/j.mrrev.2011.12.003
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
O. Melaiu (2012)
10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
J. Higgins (2003)
10.1158/0008-5472.CAN-08-2198
Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
O. Martínez-Iglesias (2009)
Relaxin promotes prostate cancer progression. Clinical cancer research : an official journal of the American Association for
S Feng (2007)
10.2307/2346830
A k-means clustering algorithm
J. Hartigan (1979)
10.1371/journal.pgen.1002165
A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression
K. Meyer (2011)
10.1158/1541-7786.MCR-07-0105
The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24
K. Huppi (2008)
10.1038/ng2088
A new multipoint method for genome-wide association studies by imputation of genotypes
J. Marchini (2007)
10.1091/mbc.E09-12-1049
Daughter Centriole Elongation Is Controlled by Proteolysis
N. Korzeniewski (2010)
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1016/j.bbcan.2012.02.002
ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
Sangphil Oh (2012)
10.1016/j.cancergencyto.2008.02.011
Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
Anitha Kamath (2008)
10.1016/S1470-2045(09)70134-2
A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres.
K. Straif (2009)
10.1038/sj.bjc.6601638
The Mesothelioma epidemic in Western Europe: an update
C. Pelucchi (2004)
10.1093/aje/kwr430
Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study.
S. Guarrera (2012)
10.1186/1742-4690-5-4
Pvt1-encoded microRNAs in oncogenesis
Gabriele B. Beck-Engeser (2007)
10.4161/epi.19801
Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays
A. Dmitriev (2012)
10.1002/GCC.2870090408
Breakpoints of burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC
R. Zeidler (1994)
10.2486/INDHEALTH.48.38
Risk assessment of lung cancer and asbestosis in workers exposed to asbestos fibers in brake shoe factory in Iran.
M. Azari (2010)
10.1097/MPA.0b013e3181bb9204
Clinicopathological Significance of Cell Cycle Regulatory Factors and Differentiation-Related Factors in Pancreatic Neoplasms
Yukinori Kamio (2010)
Genetic and epigenetic analysis of non-small cell lung cancer with NotImicroarrays
AA Dmitriev (2012)
10.1016/j.dnarep.2011.08.003
Involvement of MRE11A and XPA gene polymorphisms in the modulation of DNA double-strand break repair activity: a genotype-phenotype correlation study.
F. Ricceri (2011)
10.1371/journal.pone.0007016
Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target
S. Crispi (2009)
10.1016/j.cancergencyto.2010.06.008
Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
N. Bosco (2010)
10.1073/pnas.0910668107
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
Nasim Ahmadiyeh (2010)
10.1158/0008-5472.CAN-11-3881
Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments.
Jonathan W. Wojtkowiak (2012)
10.1038/ejhg.2011.219
A statistical method for region-based meta-analysis of genome-wide association studies in genetically diverse populations
X. Wang (2012)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.1086/512822
Mitochondrial DNA variation of modern Tuscans supports the near eastern origin of Etruscans.
A. Achilli (2007)
10.1073/pnas.0506580102
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian (2005)
10.1002/jcp.21133
The PVT‐1 oncogene is a Myc protein target that is overexpressed in transformed cells
Letizia Carramusa (2007)
10.1097/JTO.0b013e3181951ce8
In Arrayed Ranks: Array Technology in the Study of Mesothelioma
S. Gray (2009)
10.1086/519795
PLINK: a tool set for whole-genome association and population-based linkage analyses.
S. Purcell (2007)
Italy cases and review of the literature
10.1136/jcp.48.7.691-a
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
A. Zuckerman (2010)
10.1371/journal.pone.0006554
Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype
O. D. Røe (2009)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1002/ijc.27758
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
10.1128/JVI.02119-09
Adenovirus Type 5 E1A and E6 Proteins of Low-Risk Cutaneous Beta-Human Papillomaviruses Suppress Cell Transformation through Interaction with FOXK1/K2 Transcription Factors
J. Komorek (2010)
Asbestos--a legacy and a persistent problem.
F. Brims (2009)
10.1002/AJIM.20451
Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature.
V. Ascoli (2007)
10.1136/oem.46.8.529
Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia.
N. de Klerk (1989)
10.1158/1055-9965.EPI-10-0346
Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
J. Creaney (2010)



This paper is referenced by
10.1016/j.canep.2014.02.014
Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).
V. Ascoli (2014)
MALIGNANT PLEURAL MESOTHELIOMA AND INFLAMMATION
(2015)
10.21037/jtd.2017.10.41
The genetic susceptibility in the development of malignant pleural mesothelioma.
O. Melaiu (2018)
10.4081/jphr.2018.1519
Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy)
S. Visonà (2018)
10.1016/j.jtho.2018.10.163
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos‐Exposed Subjects
S. Guarrera (2019)
10.1016/j.canlet.2017.06.028
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
M. Betti (2017)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma
V. Monica (2015)
10.1093/ejcts/ezaa158
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
I. Opitz (2020)
10.1155/2015/801546
The Function and Roles of ADAMTS-7 in Inflammatory Diseases
Y. Zhang (2015)
10.1002/ajim.22717
Lung function not affected by asbestos exposure in workers with normal Computed Tomography scan
C. Schikowsky (2017)
10.1016/J.MRREV.2019.03.001
Genetic predisposition for malignant mesothelioma: A concise review.
M. Betti (2019)
10.1093/carcin/bgv097
Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
S. Tunesi (2015)
10.1007/978-3-030-16884-1_2
Asbestos and the Pathophysiology of Mesothelioma
N. Zandwijk (2019)
The influence of selected polymorphisms in matrix metalloproteinases on response to treatment and disease progression in patients with mesothelioma
Danijela Štrbac (2019)
10.1097/JTO.0000000000000436
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study
M. Lo Iacono (2015)
10.3389/fonc.2020.00445
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
L. Ferrari (2020)
10.1002/gcc.22218
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area
M. Betti (2015)
10.1016/j.yexmp.2014.06.013
Association of melanoma with intraepithelial neoplasia of the pancreas in three patients.
Felipe Fidalgo (2014)
10.1371/journal.pone.0128265
Novel Epigenetic Changes Unveiled by Monozygotic Twins Discordant for Smoking Habits
A. Allione (2015)
10.1183/09059180.00007014
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
O. D. Røe (2015)
10.3390/ht7030020
Genomics and Epigenetics of Malignant Mesothelioma
Adam P Sage (2018)
Chronic Inflammation in Malignant Mesothelioma Pathogenesis: Focus on HMGB1 Isoforms and Germline BAP1 Mutations
A. Napolitano (2015)
10.1002/gcc.22670
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes
M. Betti (2018)
10.18632/genesandcancer.124
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Noushin Nabavi (2016)
10.3892/OL.2015.3317
Effect of insulin on the mRNA expression of procollagen N-proteinases in chondrosarcoma OUMS-27 cells.
S. Akyol (2015)
10.1007/978-3-030-16884-1_4
Genetics and Epigenetics of Mesothelioma
A. Aspesi (2019)
10.1080/15287394.2019.1694612
Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes
F. Celsi (2019)
10.3390/ijms21124327
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
V. Panou (2020)
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
C. Magnani (2015)
10.1200/JCO.2018.78.5204
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
V. Panou (2018)
10.1016/j.ctrv.2020.102101
Is DNA repair a potential target for effective therapies against malignant mesothelioma?
I. Fuso Nerini (2020)
10.1101/812446
New analysis framework incorporating mixed mutual information and scalable Bayesian networks for multimodal high dimensional genomic and epigenomic cancer data
Xichun Wang (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar